Cleared Traditional

K172258 - Novasight Hybrid System

K172258 is the FDA 510(k) clearance for Novasight Hybrid System by Conavi Medical, Inc.. It is a Class 2 Cardiovascular device (product code OBJ) cleared through the Traditional 510(k) pathway after a 275-day FDA review.

K172258 · Conavi Medical, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2018
Decision
275d
Days
Class 2
Risk

K172258 is an FDA 510(k) clearance for the Novasight Hybrid System. Classified as Catheter, Ultrasound, Intravascular (product code OBJ), Class II - Special Controls.

Submitted by Conavi Medical, Inc. (Toronto, CA). The FDA issued a Cleared decision on April 27, 2018 after a review of 275 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1200 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Conavi Medical, Inc. devices

Submission Details

510(k) Number K172258 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 26, 2017
Decision Date April 27, 2018
Days to Decision 275 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
150d slower than avg
Panel avg: 125d · This submission: 275d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OBJ Catheter, Ultrasound, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1200
Definition For Intracardiac And Intraluminal Visualization Of Cardiovascular Anatomy And Physiology.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - OBJ Catheter, Ultrasound, Intravascular

All 62
Devices cleared under the same product code (OBJ) and FDA review panel - the closest regulatory comparables to K172258.
Reconnaissance PV .018 OTW Digital IVUS Catheter
K200410 · Philips Image Guided Therapy Corporation · May 2020
ACIST HDi System, ACIST Kodama Intravascular Ultrasound Catheter
K193183 · Acist Medical Systems, Inc. · Mar 2020
ACIST Kodama Intravascular Ultrasound Catheter, ACIST HDi System
K191175 · Acist Medical Systems, Inc. · Jun 2019
OptiCross 6 HD, 60 MHz Coronary Imaging Catheter (Paper DFU), OptiCross 6 HD, 60 MHz Coronary Imaging Catheter (e-DFU)
K173820 · Boston Scientific Corporation · Jan 2018
ACUSON AcuNav Volume Intracardiac Echocardiography Catheter
K173618 · Siemens Medical Solutions USA, Inc. · Dec 2017
OptiCross HD, 60 MHz Coronary Imaging Catheter (Paper DFU)
K173284 · Boston Scientific Corporation · Nov 2017